{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T22:13:24Z","timestamp":1772576004665,"version":"3.50.1"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1097\/pas.0000000000000544","type":"journal-article","created":{"date-parts":[[2015,10,31]],"date-time":"2015-10-31T14:41:04Z","timestamp":1446302464000},"page":"155-165","source":"Crossref","is-referenced-by-count":64,"title":["Clinicopathologic Comparison of Lynch Syndrome\u2013associated and \u201cLynch-like\u201d Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry"],"prefix":"10.1097","volume":"40","author":[{"given":"Anne M.","family":"Mills","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily A.","family":"Sloan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan C.","family":"Modesitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark H.","family":"Stoler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen A.","family":"Atkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher A.","family":"Moskaluk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-2-20210131","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1053\/gast.2001.27996","article-title":". The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer.","volume":"121","author":"Samowitz","year":"2001","journal-title":"Gastroenterology"},{"key":"R2-2-20210131","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/ijc.2910640613","article-title":". Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome.","volume":"64","author":"Aarnio","year":"1995","journal-title":"Int J Cancer"},{"key":"R3-2-20210131","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/jmg.2004.024299","article-title":"Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: Correction for ascertainment.","volume":"42","author":"Quehenberger","year":"2005","journal-title":"J Med Genet"},{"key":"R4-2-20210131","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10689-013-9615-1","article-title":"Cancer risk in Lynch syndrome.","volume":"12","author":"Barrow","year":"2013","journal-title":"Fam Cancer"},{"key":"R5-2-20210131","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1399-0004.2008.01125.x","article-title":". Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations.","volume":"75","author":"Barrow","year":"2009","journal-title":"Clin Genet"},{"key":"R6-2-20210131","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/gcc.20678","article-title":". Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome.","volume":"48","author":"Niessen","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"R7-2-20210131","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10689-012-9591-x","article-title":". EPCAM deletion carriers constitute a unique subgroup of Lynch syndrome patients.","volume":"12","author":"Ligtenberg","year":"2013","journal-title":"Fam Cancer"},{"key":"R8-2-20210131","first-page":"3485","article-title":". Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families.","volume":"62","author":"Wahlberg","year":"2002","journal-title":"Cancer Res"},{"key":"R9-2-20210131","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1200\/JCO.2000.18.11.2193","article-title":". Population-based molecular detection of hereditary nonpolyposis colorectal cancer.","volume":"18","author":"Salovaara","year":"2000","journal-title":"J Clin Oncol"},{"key":"R10-2-20210131","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1158\/1078-0432.CCR-0956-3","article-title":". Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer.","volume":"10","author":"de Jong","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R11-2-20210131","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1001\/jama.293.16.1986","article-title":". Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer.","volume":"293","author":"Pinol","year":"2005","journal-title":"JAMA"},{"key":"R12-2-20210131","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0002-9440(10)63841-2","article-title":". Conventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors.","volume":"162","author":"Hendriks","year":"2003","journal-title":"Am J Pathol"},{"key":"R13-2-20210131","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djh034","article-title":". Revised bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.","volume":"96","author":"Umar","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"R14-2-20210131","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/ajg.2014.186","article-title":". Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US multi-society task force on colorectal cancer.","volume":"109","author":"Giardiello","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"R15-2-20210131","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/jmg.37.9.641","article-title":". Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1.","volume":"37","author":"Syngal","year":"2000","journal-title":"J Med Genet"},{"key":"R16-2-20210131","doi-asserted-by":"crossref","first-page":"e79737","DOI":"10.1371\/journal.pone.0079737","article-title":". Prevalence of Lynch syndrome among patients with newly diagnosed endometrial cancers.","volume":"8","author":"Egoavil","year":"2013","journal-title":"PLoS One"},{"key":"R17-2-20210131","doi-asserted-by":"crossref","first-page":"7810","DOI":"10.1158\/0008-5472.CAN-06-1114","article-title":". Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.","volume":"66","author":"Hampel","year":"2006","journal-title":"Cancer Res"},{"key":"R18-2-20210131","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ygyno.2013.04.022","article-title":". Implementation of tumor testing for Lynch syndrome in endometrial cancers at a large academic medical center.","volume":"130","author":"Moline","year":"2013","journal-title":"Gynecol Oncol"},{"key":"R19-2-20210131","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1097\/PAS.0000000000000321","article-title":". Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer.","volume":"38","author":"Mills","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R20-2-20210131","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/PAS.0000000000000177","article-title":". Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.","volume":"38","author":"Rabban","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R21-2-20210131","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ygyno.2015.01.535","article-title":". Impact of an immunohistochemistry-based universal screening protocol for Lynch syndrome in endometrial cancer on genetic counseling and testing.","volume":"137","author":"Frolova","year":"2015","journal-title":"Gynecol Oncol"},{"key":"R22-2-20210131","first-page":"183","article-title":". Clinical problems of colorectal cancer and endometrial cancer cases with unknown cause of tumor mismatch repair deficiency (suspected Lynch syndrome).","volume":"7","author":"Buchanan","year":"2014","journal-title":"Appl Clin Genet"},{"key":"R23-2-20210131","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/gim.2014.147","article-title":". Guideline Development Group. American College of Medical Genetics and Genomics Professional Practice and Guidelines Committee and National Society of Genetic Counselors Practice Guidelines Committee. A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment.","volume":"17","author":"Hampel","year":"2015","journal-title":"Genet Med"},{"key":"R24-2-20210131","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1053\/j.gastro.2014.01.041","article-title":"Differentiating lynch-like from Lynch syndrome.","volume":"146","author":"Carethers","year":"2014","journal-title":"Gastroenterology"},{"key":"R26-2-20210131","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/1066896909332117","article-title":". Lynch syndromerelated endometrial carcinomas show a high frequency of nonendometrioid types and of high FIGO grade endometrioid types.","volume":"18","author":"Carcangiu","year":"2010","journal-title":"Int J Surg Pathol"},{"key":"R27-2-20210131","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/cncr.21560","article-title":". Pathologic features of endometrial carcinoma associated with HNPCC: a comparison with sporadic endometrial carcinoma.","volume":"106","author":"Broaddus","year":"2006","journal-title":"Cancer"},{"key":"R28-2-20210131","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/jcp.2009.064949","article-title":"Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma.","volume":"62","author":"Garg","year":"2009","journal-title":"J Clin Pathol"},{"key":"R29-2-20210131","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/modpathol.2010.41","article-title":". Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms.","volume":"23","author":"Tafe","year":"2010","journal-title":"Mod Pathol"},{"key":"R30-2-20210131","doi-asserted-by":"crossref","first-page":"438","DOI":"10.5858\/arpa.2011-0461-RS","article-title":"Undifferentiated endometrial carcinoma: a diagnosis frequently overlooked.","volume":"137","author":"Al-Loh","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"R32-2-20210131","first-page":"151","article-title":". Adenocarcinoma, adenoacanthoma, and mixed adenosquamous carcinoma of the endometrium.","volume":"22","author":"Pekin","year":"2001","journal-title":"Eur J Gynaecol Oncol"},{"key":"R33-2-20210131","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/ajcp\/77.6.655","article-title":"Carcinoma of the endometrium. IV. mixed adenosquamous carcinoma. A clinical-pathological study of 68 cases with long-term follow-up.","volume":"77","author":"Alberhasky","year":"1982","journal-title":"Am J Clin Pathol"},{"key":"R34-2-20210131","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/1097-0142(19911115)68:10<2293::AID-CNCR2820681032>3.0.CO;2-V","article-title":". The significance of squamous differentiation in endometrial carcinoma. Data from a gynecologic oncology group study.","volume":"68","author":"Zaino","year":"1991","journal-title":"Cancer"},{"key":"R35-2-20210131","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/1097-0142(197211)30:5<1307::AID-CNCR2820300524>3.0.CO;2-R","article-title":"Adenoacanthoma and mixed adenosquamous carcinoma of the endometrium. A clinicopathologic study.","volume":"30","author":"Silverberg","year":"1972","journal-title":"Cancer"},{"key":"R36-2-20210131","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/IGC.0b013e31828eed9c","article-title":". Women 50 years or younger with endometrial cancer: the argument for universal mismatch repair screening and potential for targeted therapeutics.","volume":"23","author":"Ring","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"R38-2-20210131","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/gutjnl-2013-306567","article-title":". Role of tumour molecular and pathology features to estimate colorectal cancer risk for first-degree relatives.","volume":"64","author":"Win","year":"2015","journal-title":"Gut"},{"key":"R39-2-20210131","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1056\/NEJMoa043146","article-title":". Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).","volume":"352","author":"Hampel","year":"2005","journal-title":"N Engl J Med"},{"key":"R41-2-20210131","first-page":"447","article-title":"Weiser MR, et al..","volume":"35","author":"Shia","year":"2011","journal-title":"Immunohistochemical staining for DNA mismatch repair proteins in intestinal tract carcinoma: how reliable are biopsy samples Am J Surg Pathol"},{"key":"R42-2-20210131","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3109\/00313025.2010.493862","article-title":". DNA mismatch repair enzyme immunohistochemistry in colorectal cancer: A comparison of biopsy and resection material.","volume":"42","author":"Kumarasinghe","year":"2010","journal-title":"Pathology"},{"key":"R43-2-20210131","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3322\/canjclin.56.4.213","article-title":". Diagnostic approach and management of Lynch syndrome (hereditary nonpolyposis colorectal carcinoma): a guide for clinicians.","volume":"56","author":"Hendriks","year":"2006","journal-title":"CA Cancer J Clin"},{"key":"R44-2-20210131","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/GIM.0b013e31818fa2ff","article-title":"Recommendations from the EGAPP working group: Genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives.","volume":"11","year":"2009","journal-title":"Genet Med"},{"key":"R45-2-20210131","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/gcc.10094","article-title":". A 10-mb paracentric inversion of chromosome arm 2p inactivates MSH2 and is responsible for hereditary nonpolyposis colorectal cancer in a North-American kindred.","volume":"35","author":"Wagner","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"R46-2-20210131","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10689-013-9688-x","article-title":"Inversion of exons 1-7 of the MSH2 gene is a frequent cause of unexplained Lynch syndrome in one local population.","volume":"13","author":"Rhees","year":"2014","journal-title":"Fam Cancer"},{"key":"R47-2-20210131","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/gcc.20556","article-title":"The 10-mb paracentric inversion of chromosome arm 2p in activating MSH2 and causing hereditary nonpolyposis colorectal cancer: Re-annotation and mutational mechanisms.","volume":"47","author":"Chen","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"R48-2-20210131","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1053\/j.gastro.2014.08.041","article-title":". Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations.","volume":"147","author":"Haraldsdottir","year":"2014","journal-title":"Gastroenterology"},{"key":"R49-2-20210131","doi-asserted-by":"crossref","first-page":"e59064","DOI":"10.1371\/journal.pone.0059064","article-title":". MLH1 promoter methylation frequency in colorectal cancer patients and related clinicopathological and molecular features.","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"R50-2-20210131","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1136\/gut.48.6.821","article-title":". Microsatellite instability and the clinicopathological features of sporadic colorectal cancer.","volume":"48","author":"Ward","year":"2001","journal-title":"Gut"},{"key":"R51-2-20210131","first-page":"2277","article-title":"Equality in Lynch syndrome screening: why should we hold patients with endometrial cancer to a different standard J Clin Oncol.","volume":"32","author":"Moline","year":"2014","journal-title":""}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000000544","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:45:53Z","timestamp":1620967553000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201602000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000544","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]}}}